Selective inhibition of FGFR4 by INCB062079 is efficacious in models of FGF19-and FGFR4-dependent cancers

被引：3
|
作者：
Liu, Phillip C. C.
Lu, Liang
Bowman, Kevin
Stubbs, Matthew C.
Wu, Liangxing
DiMatteo, Darlise
Condon, Sindy
Klabe, Ronald
Qian, Ding-Quan
Wen, Xiaoming
Collier, Paul
Gallagher, Karen
Hansbury, Michael
He, Xin
Ruggeri, Bruce
Yang, Yan-ou
Covington, Maryanne
Burn, Timothy C.
Diamond-Fosbenner, Sharon
Wynn, Richard
Huber, Reid
Yao, Wenqing
Yeleswaram, Swamy
Scherle, Peggy
Hollis, Gregory
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2100
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2100
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The novel FGFR4-selective inhibitor INCB062079 is efficacious in models of hepatocellular carcinoma harboring FGF19 amplification
    Ruggeri, Bruce
    Stubbs, Matthew
    Yang, Yan-ou
    Juvekar, Ashish
    Lu, Liang
    Condon, Sindy
    DiMatteo, Darlise
    Wen, Xiaoming
    Collier, Paul
    Burn, Timothy
    Wu, Liangxing
    Wilson, Daniel
    Yeleswaram, Swamy
    Roberts, Alan
    Yao, Wenqing
    Hollis, Gregory
    Huber, Reid
    Scherle, Peggy
    Liu, Phillip C. C.
    CANCER RESEARCH, 2017, 77
  • [2] NVP-FGF401: Cellular and in vivo profile of a novel highly potent and selective FGFR4 inhibitor for the treatment of FGF19/FGFR4/KLB+ tumors
    Weiss, Andreas
    Porta, Diana Graus
    Reimann, Flavia
    Buhles, Alexandra
    Stamm, Christelle
    Fairhurst, Robin A.
    Kinyamu-Akunda, Jacqueline
    Sterker, Dario
    Murakami, Masato
    Wartmann, Markus
    Wang, Youzhen
    Engelman, Jeffrey A.
    Hofmann, Francesco
    Sellers, Wiliam R.
    CANCER RESEARCH, 2017, 77
  • [3] Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
    Yang, Chaofeng
    Jin, Chengliu
    Li, Xiaokun
    Wang, Fen
    McKeehan, Wallace L.
    Luo, Yongde
    PLOS ONE, 2012, 7 (03):
  • [4] Expression of FGF19/FGFR4 related biomarkers in hepatocellular carcinoma
    Lin, Zhong-Zhe
    Jeng, Yung -Ming
    Hsu, Chiun
    Tsai, I-Lun
    Chen, Kuan-Yu
    Hu, Fu -Chang
    Hsu, Chih-Hung
    Hsu, Hey-Chi
    Cheng, Ann-Lii
    CANCER RESEARCH, 2016, 76
  • [5] Making way for suppressing the FGF19/FGFR4 axis in cancer
    Prieto-Dominguez, Nestor
    Shull, Austin Y.
    Teng, Yong
    FUTURE MEDICINAL CHEMISTRY, 2018, 10 (20) : 2457 - 2469
  • [6] Soluble FGFR4 extracellular domain inhibits FGF19-induced activation of FGFR4 signaling and prevents nonalcoholic fatty liver disease
    Chen, Qiang
    Jiang, Yuan
    An, Yuan
    Zhao, Na
    Zhao, Yang
    Yu, Chundong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 409 (04) : 651 - 656
  • [7] FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
    Lixia Gao
    Xuli Wang
    Yaoliang Tang
    Shuang Huang
    Chien-An Andy Hu
    Yong Teng
    Journal of Experimental & Clinical Cancer Research, 36
  • [8] FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation
    Wu, Xinle
    Ge, Hongfei
    Lemon, Bryan
    Vonderfecht, Steven
    Weiszmann, Jennifer
    Hecht, Randy
    Gupte, Jamila
    Hager, Todd
    Wang, Zhulun
    Lindberg, Richard
    Li, Yang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (08) : 5165 - 5170
  • [9] Combined inhibition of FGFR4 and VEGFR signaling enhances efficacy in FGF19 driven hepatocellular carcinoma
    Zhao, Xuesong
    Joshi, Jaya Julie
    Aird, Daniel
    Karr, Craig
    Yu, Kun
    Huang, Chialing
    Colombo, Federico
    Virrankoski, Milena
    Prajapati, Sudeep
    Selvaraj, Anand
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (06): : 2733 - +
  • [10] Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis
    Wu, Xinle
    Li, Yang
    AGING-US, 2009, 1 (12): : 1023 - 1027
12345